Development of a questionnaire to assess experience and preference of intranasal corticosteroids in patients with allergic rhinitis
{{output}}
Background: Allergic rhinitis affects 10%-20% of the US population. Its chronic nature, combined with patients' perceptions of safety/efficacy, administration, and sensory attributes of nasal sprays (corticosteroids), impact pati... ...
